Evidence map›Paper›PMID 39514438›Full record

ArticleRevista medica del Instituto Mexicano del Seguro Social2024

[Metastatic breast melanoma in a man: Case report].

Yeudiel Suro-Santos, Daniel Alberto Meza-Martínez, Juan Reyna-Espinosa, Julia Oliva De Leija-Portilla, Víctor Hugo Castillo-Ávila, Jorge Alejandro Serrato-Ruiz, Diego Emilio Gómez-López

Abstract readCase ReportsEnglish Abstract
In one paragraph

Article in Revista medica del Instituto Mexicano del Seguro Social, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yeudiel Suro-SantosInstituto Mexicanoano del Seguro Social, Hospital General de Zona No. 33, Servicio de Cirugía General. Monterrey, Nuevo León, México.ORCID 0000-0002-6562-8371
Daniel Alberto Meza-MartínezInstituto Mexicanoano del Seguro Social, Hospital General de Zona No. 33, Servicio de Cirugía General. Monterrey, Nuevo León, México.ORCID 0009-0001-7731-8039b,
Juan Reyna-EspinosaInstituto Mexicano del Seguro Social, Unidad Médica de Alta Especialidad No. 25, Departamento de Patología. Monterrey, Nuevo León, México.ORCID 0009-0003-2445-2255
Julia Oliva De Leija-PortillaInstituto Mexicano del Seguro Social, Unidad Médica de Alta Especialidad No. 25, Departamento de Patología. Monterrey, Nuevo León, México.ORCID 0009-0006-6743-3646
Víctor Hugo Castillo-ÁvilaInstituto Mexicanoano del Seguro Social, Hospital General de Zona No. 33, Servicio de Cirugía General. Monterrey, Nuevo León, México.ORCID 0000-0001-6211-436X
Jorge Alejandro Serrato-RuizInstituto Mexicanoano del Seguro Social, Hospital General de Zona No. 33, Servicio de Cirugía General. Monterrey, Nuevo León, México.ORCID 0009-0007-9114-6388
Diego Emilio Gómez-LópezInstituto de Seguridad y Servicios Sociales de los Trabajadores del Estado, Hospital Regional de Monterrey, Departamento de Medicina Interna. Monterrey, Nuevo León, México.ORCID 0009-0001-4280-3755

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Malignant melanoma is a skin neoplasm that typically does not invade the breast, making its spread to the breast tissue in a male patient uncommon. When it metastasizes to the breast, it can present as a palpable mass or even be asymptomatic. Ultrasound allows for the detection of round hypoechoic lesions, while mammography detects well-defined nodules with increased density. The aim of this article is to describe the approach to a male patient with a breast mass and suspected melanoma, as well as the importance of immunohistochemistry for proper differentiation. Clinical Case: A 72-year-old male patient presented with a pigmented lesion on the sternum, an axillary tumor, and a right breast mass, which had been evolving for the past two years. He underwent resection, excisional biopsy, and simple mastectomy, respectively. superficial spreading melanoma with right breast metastases was documented. Immunohistochemistry supported the diagnosis, after positivity for HMB-45 and S100 was found in the examined samples. Conclusions: Metastatic melanoma in the male breast is an exceedingly rare finding. Immunohistochemistry plays a pivotal role in both diagnostic assessment and prognosis, as it guides treatment determination, which encompasses local and systemic interventions. For patients presenting as in this case, the optimal approach involves wide tumor resection with axillary lymph node dissection, coupled with adjuvant systemic therapy. Hence, case reporting is imperative to share diagnostic approaches in such patients and provide appropriate management strategies.

Indexed as

Breast Neoplasms, MaleMelanomaSkin NeoplasmsAgedHumansImmunohistochemistryMaleBreastBreast NeoplasmsMaleMelanomaNeoplasm Metastasis

Identifiers

PMID39514438
PMCPMC12143902

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.